TYBR Health discloses $14.35 million raised in ongoing equity offering
The Houston-based biotechnology company filed a Form D showing sales toward a $30 million target, with $15.65 million still to be sold.
SEC filing
Latest
1 story
Sign inSign in1 story
The Houston-based biotechnology company filed a Form D showing sales toward a $30 million target, with $15.65 million still to be sold.
SEC filing